Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2018

01-02-2018 | Research Article

Diabetes care in Qatar: a survey of pharmacists’ activities, attitudes and knowledge

Authors: Maguy Saffouh El Hajj, Safae E. Abu Yousef, Meena Ali Basri

Published in: International Journal of Clinical Pharmacy | Issue 1/2018

Login to get access

Abstract

Background Diabetes mellitus is recognized as a major public health issue and is one of the top ten causes of death in Qatar. Objective To describe the activities, and attitudes of Qatar pharmacists toward diabetes, to measure their diabetes knowledge and to assess their perceived barriers for diabetes care. Setting Community and ambulatory pharmacies in Qatar. Method Study objectives were addressed in a cross sectional survey of community and ambulatory pharmacists in Qatar. A phone call explaining the study was made to all community and ambulatory pharmacists in Qatar. Consenting pharmacists anonymously completed the survey either online or as paper. Main outcome measure Diabetes related activities, knowledge, attitudes and perceived barriers. Results Over 7 months, 126 surveys were collected (28% response rate). The majority of pharmacists always or often counselled patients on the appropriate time to take each medication and on medication side effects (90%, n = 100/111 and 73%, n = 81/111 respectively). Yet around 50% always or often provided education on the importance of screening for nephropathy (n = 59/112) and retinopathy (n = 58/109). In addition, 41% always or often provided education about the importance of immunization (n = 45/111) and 45% always or often provided therapy recommendations to physicians (n = 49/111). Using Diabetes Attitude Scale-3, most respondents had positive attitudes toward the need for special training, psychosocial impact of diabetes, and patient autonomy. Around 25% (n = 32/126) scored less than 6 out of 10 on the diabetes related knowledge test. The top three barriers for providing diabetes services were lack of time (53%, n = 67/126) shortage of personnel (42%, n = 53/126) and lack of private counseling area (42%, n = 53/126). Conclusion Qatar pharmacists mainly provide basic services for diabetic patients. They have an average diabetes related knowledge. Yet overall, they have positive attitudes toward diabetes, which is a vital component of any successful diabetes care service.
Literature
4.
go back to reference Cranor CW, Christensen DB. The asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149–59. Cranor CW, Christensen DB. The asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149–59.
5.
go back to reference Guirguis LM. Diabetes: are pharmacists making an impact on patient outcomes? CPJ/RPJ. 2003;136:24–8. Guirguis LM. Diabetes: are pharmacists making an impact on patient outcomes? CPJ/RPJ. 2003;136:24–8.
8.
go back to reference The American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2017;40(suppl 1):S1–132. The American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2017;40(suppl 1):S1–132.
9.
go back to reference Sisson E, Kuhn C. Pharmacist roles in the management of patients with type 2 diabetes. J Am Pharm Assoc. 2009;49(suppl 1):S41–5.CrossRef Sisson E, Kuhn C. Pharmacist roles in the management of patients with type 2 diabetes. J Am Pharm Assoc. 2009;49(suppl 1):S41–5.CrossRef
10.
go back to reference Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm. 2016;22(5):493–515.CrossRefPubMed Pousinho S, Morgado M, Falcão A, Alves G. Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials. J Manag Care Spec Pharm. 2016;22(5):493–515.CrossRefPubMed
11.
go back to reference Campbell RK. Role of the pharmacist in diabetes management. Am J Health Syst Pharm. 2002;59(suppl 9):S18–21.PubMed Campbell RK. Role of the pharmacist in diabetes management. Am J Health Syst Pharm. 2002;59(suppl 9):S18–21.PubMed
12.
go back to reference Ciardulli LM, Goode JR. Using health observances to promote wellness in community pharmacies. J Am Pharm Assoc. 2003;43(1):61–8. Ciardulli LM, Goode JR. Using health observances to promote wellness in community pharmacies. J Am Pharm Assoc. 2003;43(1):61–8.
13.
go back to reference The American Diabetes Association. National standards for diabetes self-management education and support. Diabetes Care. 2014;37(suppl 1):S144–53. The American Diabetes Association. National standards for diabetes self-management education and support. Diabetes Care. 2014;37(suppl 1):S144–53.
15.
go back to reference Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250–64.CrossRefPubMed Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250–64.CrossRefPubMed
16.
go back to reference Wang Y, Yeo QQ, Ko Y. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review. Diabet Med. 2016;33(4):421–7.CrossRefPubMed Wang Y, Yeo QQ, Ko Y. Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review. Diabet Med. 2016;33(4):421–7.CrossRefPubMed
17.
go back to reference Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–36.CrossRefPubMed Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–36.CrossRefPubMed
18.
go back to reference Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions, part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569–82.CrossRefPubMed Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions, part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569–82.CrossRefPubMed
21.
go back to reference Bener A, Kim EJ, Mutlu F, Eliyan A, Delghan H, Nofal E, et al. Burden of diabetes mellitus attributable to demographic levels in Qatar: an emerging public health problem. Diabetes Metab Syndr. 2014;8(4):216–20.CrossRefPubMed Bener A, Kim EJ, Mutlu F, Eliyan A, Delghan H, Nofal E, et al. Burden of diabetes mellitus attributable to demographic levels in Qatar: an emerging public health problem. Diabetes Metab Syndr. 2014;8(4):216–20.CrossRefPubMed
22.
go back to reference Jackson C, Furnham A. Designing and analyzing questionnaires and surveys: a manual for health professionals and administrators. London: Whurr Publishers; 2000. Jackson C, Furnham A. Designing and analyzing questionnaires and surveys: a manual for health professionals and administrators. London: Whurr Publishers; 2000.
23.
go back to reference Younis WS, Campbell S, Slack MK. Pharmacists’ attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother. 2001;35(7–8):841–5.CrossRefPubMed Younis WS, Campbell S, Slack MK. Pharmacists’ attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother. 2001;35(7–8):841–5.CrossRefPubMed
24.
go back to reference Simpson S, Haggarty S, Johnson J, Schindel T, Ross T, Lewanczuk R. Survey of pharmacist activities and attitudes in diabetes management. Can Pharm J. 2009;142(3):127–34.CrossRef Simpson S, Haggarty S, Johnson J, Schindel T, Ross T, Lewanczuk R. Survey of pharmacist activities and attitudes in diabetes management. Can Pharm J. 2009;142(3):127–34.CrossRef
25.
go back to reference Fitzgerald JT, Funnell MM, Hess GE, Barr PA, Anderson RM, Hiss RG, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998;21:706–10.CrossRefPubMed Fitzgerald JT, Funnell MM, Hess GE, Barr PA, Anderson RM, Hiss RG, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998;21:706–10.CrossRefPubMed
26.
go back to reference Chen HY, Lee TY, Huang WT, Chang CJ, Chen CM. The short-term impact of a continuing education program on pharmacists’ knowledge and attitudes toward diabetes. Am J Pharm Educ. 2004;68(5):121.CrossRef Chen HY, Lee TY, Huang WT, Chang CJ, Chen CM. The short-term impact of a continuing education program on pharmacists’ knowledge and attitudes toward diabetes. Am J Pharm Educ. 2004;68(5):121.CrossRef
27.
go back to reference Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. The third version of the Diabetes Attitude Scale. Diabetes Care. 1998;21(9):1403–7.CrossRefPubMed Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. The third version of the Diabetes Attitude Scale. Diabetes Care. 1998;21(9):1403–7.CrossRefPubMed
29.
go back to reference Wibowo Y, Parsons R, Sunderland B, Hughes J. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey. Int J Clin Pharm. 2015;37(5):873–82.CrossRefPubMed Wibowo Y, Parsons R, Sunderland B, Hughes J. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey. Int J Clin Pharm. 2015;37(5):873–82.CrossRefPubMed
30.
31.
go back to reference Kjome RL, Sandberg S, Granås AG. Diabetes care in Norwegian pharmacies: a descriptive study. Pharm World Sci. 2008;30(2):191–8.CrossRefPubMed Kjome RL, Sandberg S, Granås AG. Diabetes care in Norwegian pharmacies: a descriptive study. Pharm World Sci. 2008;30(2):191–8.CrossRefPubMed
33.
go back to reference Shrestha M, Maharjan R, Prajapati A, Ghimire S, Shrestha N, Banstola A. Assessment of knowledge and practice of community pharmacy personnel on diabetes mellitus management in Kathmandu district: a cross sectional descriptive study. J Diabetes Metab Disord. 2015;14:71.CrossRefPubMedPubMedCentral Shrestha M, Maharjan R, Prajapati A, Ghimire S, Shrestha N, Banstola A. Assessment of knowledge and practice of community pharmacy personnel on diabetes mellitus management in Kathmandu district: a cross sectional descriptive study. J Diabetes Metab Disord. 2015;14:71.CrossRefPubMedPubMedCentral
34.
go back to reference Douglas E, Power A, Hudson S. Pharmaceutical care of the patient with diabetes mellitus: pharmacists’ priorities for services and educational needs in Scotland. Int J Pharm Pract. 2007;15:47–52.CrossRef Douglas E, Power A, Hudson S. Pharmaceutical care of the patient with diabetes mellitus: pharmacists’ priorities for services and educational needs in Scotland. Int J Pharm Pract. 2007;15:47–52.CrossRef
35.
go back to reference Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the early ACTID randomised controlled trial. Lancet. 2011;378(9786):129–39.CrossRefPubMed Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the early ACTID randomised controlled trial. Lancet. 2011;378(9786):129–39.CrossRefPubMed
36.
go back to reference Coppell KJ, Kataoka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—lifestyle over and above drugs in diabetes (LOADD) study: randomised controlled trial. BMJ. 2010;341:c3337.CrossRefPubMedPubMedCentral Coppell KJ, Kataoka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—lifestyle over and above drugs in diabetes (LOADD) study: randomised controlled trial. BMJ. 2010;341:c3337.CrossRefPubMedPubMedCentral
37.
go back to reference Ibrahim MM, Arafat Y, Awaisu A, Owusu Y, Colagiuri S, AlHafiz M. Association between stages of change and medication adherence among diabetic patients in a primary health care setting in Qatar: a preliminary study. Value Health. 2016;19(7):A676.CrossRef Ibrahim MM, Arafat Y, Awaisu A, Owusu Y, Colagiuri S, AlHafiz M. Association between stages of change and medication adherence among diabetic patients in a primary health care setting in Qatar: a preliminary study. Value Health. 2016;19(7):A676.CrossRef
38.
go back to reference Bener A, Laftah F, Hamaq A, Daghash M, Abdullated W. A study of diabetes complications in an endogamous population: an emerging public health burden. Diabetes Metab Syndr. 2014;8(2):108–14.CrossRefPubMed Bener A, Laftah F, Hamaq A, Daghash M, Abdullated W. A study of diabetes complications in an endogamous population: an emerging public health burden. Diabetes Metab Syndr. 2014;8(2):108–14.CrossRefPubMed
39.
go back to reference Wilbur K, Al Amer M. An inventory of diabetes care in Qatar. Pract Diabetes Int. 2011;28(1):35–6.CrossRef Wilbur K, Al Amer M. An inventory of diabetes care in Qatar. Pract Diabetes Int. 2011;28(1):35–6.CrossRef
40.
go back to reference El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar. J Eval Clin Pract. 2016;22(3):329–40.CrossRefPubMed El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar. J Eval Clin Pract. 2016;22(3):329–40.CrossRefPubMed
41.
go back to reference Wilbur K, Beniles A, Hammuda A. Physician perceptions of pharmacist roles in a primary care setting in Qatar. Glob Health. 2012;8:12.CrossRef Wilbur K, Beniles A, Hammuda A. Physician perceptions of pharmacist roles in a primary care setting in Qatar. Glob Health. 2012;8:12.CrossRef
42.
go back to reference Tawfik H, Bashwar Z, Al-Ali A, Salem M, Abdelbagi I. Improving physician’s adherence to completing vaccination schedules for patients with type 2 diabetes attending non-communicable diseases clinics in West Bay Health Center, Qatar. BMJ Qual Improv Rep. 2015;4(1):u208497.w3388.CrossRefPubMedPubMedCentral Tawfik H, Bashwar Z, Al-Ali A, Salem M, Abdelbagi I. Improving physician’s adherence to completing vaccination schedules for patients with type 2 diabetes attending non-communicable diseases clinics in West Bay Health Center, Qatar. BMJ Qual Improv Rep. 2015;4(1):u208497.w3388.CrossRefPubMedPubMedCentral
43.
go back to reference American Society of Health System Pharmacists Council on Professional Affairs. ASHP guidelines on the pharmacist’s role in immunization. Am J Health Syst Pharm. 2003;60(13):1371–7. American Society of Health System Pharmacists Council on Professional Affairs. ASHP guidelines on the pharmacist’s role in immunization. Am J Health Syst Pharm. 2003;60(13):1371–7.
44.
go back to reference Bisheya AF, El-Mijbri SB, Beshyah SA, Sherif I. Community pharmacists’ knowledge, attitude and practice towards diabetes care in Tripoli, Libya. Ibnosina J Med Biomed Sci. 2011;3(3):89–95.CrossRef Bisheya AF, El-Mijbri SB, Beshyah SA, Sherif I. Community pharmacists’ knowledge, attitude and practice towards diabetes care in Tripoli, Libya. Ibnosina J Med Biomed Sci. 2011;3(3):89–95.CrossRef
45.
go back to reference The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015;64:631–42.CrossRef The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015;64:631–42.CrossRef
46.
go back to reference The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.CrossRefPubMedCentral The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.CrossRefPubMedCentral
47.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34. Lancet. 1998;352:854–65.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34. Lancet. 1998;352:854–65.CrossRef
48.
go back to reference Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh. Epidemiology of diabetes complications experience (1983–2005). Arch Intern Med. 2009;169:1307–16. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh. Epidemiology of diabetes complications experience (1983–2005). Arch Intern Med. 2009;169:1307–16.
49.
go back to reference El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–43.CrossRefPubMed El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–43.CrossRefPubMed
50.
go back to reference El Hajj MS, Kheir N, Al-Zaidan MB, Jewesson PJ. Pharmacist characteristics, medication use perceptions and professional satisfaction: a first national survey in the state of Qatar. J Healthc Leadersh. 2011;3:9–28.CrossRef El Hajj MS, Kheir N, Al-Zaidan MB, Jewesson PJ. Pharmacist characteristics, medication use perceptions and professional satisfaction: a first national survey in the state of Qatar. J Healthc Leadersh. 2011;3:9–28.CrossRef
Metadata
Title
Diabetes care in Qatar: a survey of pharmacists’ activities, attitudes and knowledge
Authors
Maguy Saffouh El Hajj
Safae E. Abu Yousef
Meena Ali Basri
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0562-z

Other articles of this Issue 1/2018

International Journal of Clinical Pharmacy 1/2018 Go to the issue